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Background: The life expectancy of individuals with CF has increased to 33 years. Thus, issues such as quality of life and psychological well-
being, previously thought to be of lesser importance than physical well-being, are now recognised as significant factors. This study examined the
interrelationships between quality of life, family functioning, individual psychopathology and optimism of adolescents with CF.
Methods: Adolescents attending the CF clinic completed a number of questionnaires. Quality of Life was measured using the Cystic Fibrosis
Questionnaire, family functioning by the Family Environment Scale (3rd edition), general psychopathology with the Symptom Checklist-90-
Revised and optimism for the future by the Hunter Opinions and Personal Expectations Scale. Disease severity was assessed using the
Shwachman score and spirometry at the time of questionnaire completion.
Results: The level of psychopathology (12.5% of those 13 years and over) in the group was lower than that reported for young people in
Australia (15–20%). The results indicated that young people with a delayed diagnosis and those who are alienated from their families may be
in need of additional psychosocial support. The group was hopeful and positive about their future and these attributes were independent of
clinical measures of disease severity. In general, these young people scored relatively highly on the quality of life scale. For example the
mean standardised score for physical functioning was 70 points, for respiratory symptoms was 63 points and for emotional state was 78
points. Increased levels of psychopathology and lack of hope for the future were however associated with lower ratings on a number of
quality of life measures. Family cohesiveness, expressiveness and organization were associated with better psychological functioning in the
young people.
Conclusions: Adolescents with CF appear to be a psychologically well functioning and well-adjusted group. These findings support the
importance of a more sophisticated model of well-being for adolescents with CF, which explores the young person’s views on their quality of
life and wider support frameworks rather than relying solely on measures of physical health to gauge well-being.
D 2005 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Adolescents; Family functioning; Cystic fibrosis; Psychopathology; Quality of life; Optimism
1. Introduction The median life expectancy is now 33.4 years [1]. WithinThe life expectancy of children born with cystic fibrosis
(CF) has been steadily increasing over the past two decades
as a result of major advances in diagnosis and treatment.1569-1993/$ - see front matter D 2005 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2005.02.004
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E-mail address: karenm8@chw.edu.au (K.O. McKay).this context, quality of life is increasingly recognised as an
important therapeutic consideration and variable to measure.
Quality of Life (QoL) focuses on the individual’s subjective
evaluation of his or her daily functioning and psychological
well-being and is patient rather than physician centred [2].
For a good quality of life factors such as social functioning,
peer relationships and emotional well-being are considered
alongside measures of physical well-being [2].
In a study using the Quality of Well-being Scale (QWB)
with children with cystic fibrosis, QoL has been shown to4 (2005) 135 – 144ed by Elsevier B.V. All rights reserved.
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and as the number of concurrent medical conditions increase
[3]. In another study using the QWB, proportionally higher
scores were obtained by CF patients with better lung
function and greater exercise tolerance [4]. This would
suggest an inevitable association between physical function-
ing and quality of life. However, the QWB has limited
sensitivity and responds more to the extent of physician-
determined treatment than to QoL [4]. There has also been
some criticism of the QWB particularly in relation to how it
captures the multidimensional aspects of QOL rather than
just the physical symptoms associated with the disease [2].
The Ontario Child Health Survey estimated the increased
risk of psychiatric disorders for those with chronic
conditions and an accompanying disability, to be over three
times higher than for healthy children [5]. Studies examin-
ing general psychopathology in CF groups have yielded
mixed findings as to whether young people with CF have
increased rates of psychopathology when compared to their
healthy peers [6]. These mixed findings can be attributed to
the influence of mediating variables such as age, gender,
disease severity, and family functioning on the measurement
of psychopathology [7]. The literature suggesting high
prevalence of significant emotional problems in chronically
ill adolescents [8] tended to come from early research in CF
when diagnosis was difficult and when the prognosis was
far worse than currently due to more rudimentary treatment
regimens. Other studies since this time have challenged this
assumption [9–12].
There has been a shift towards measuring psychological
well-being in chronic illness by exploring a range of stresses
and the way these elicit different adverse responses and
coping behaviour in young people and their families.
Although it is clear that young people with CF have to cope
with an extra burden, it is not inevitable that this should lead
to pathology. Studies which have looked at family and
parental functioning in CF indicate that parents of children
with CF experience greater stress and burdens than parents of
healthy children. However, family functioning appears to be
similar whether or not a family has a child with CF. Higher
levels of distress, an avoidant coping strategy and low levels
of family support are associated with poor psychological
adjustment [13]. The degree to which parents can support the
young person with cystic fibrosis appears to be very
important in mediating the young person’s psychological
well-being. Ratings of non-supportive behaviours for family
members have been found to be the strongest predictor for
psychological adjustment [14]. Another dimension which
may also impact on adaptive health outcomes is a variety of
religious and spiritual coping strategies [15].
Traditionally, adolescent research has focused on risk
factors, thus protective factors are less well understood [16].
There has been interest in the concept of hope for the future
or optimism as a measure of resilience [17], which may be
particularly pertinent to chronic illness. Gudas and col-
leagues, using a somewhat crude measure of optimismsuggested that it is positively correlated with treatment
compliance in CF [18]. Research in other areas has pointed
to importance of hopefulness in effective therapy [19] and in
coping in young people who have been sexually abused [20].
The aim of the present study was to look at the
interrelationship of quality of life, family functioning,
individual psychopathology and optimism in order to
develop a clearer picture of which factors may combine to
produce positive psychological well-being and quality of
life in adolescents with cystic fibrosis.2. Materials and methods
2.1. Subjects
All adolescents aged 12–18 years attending specialist
cystic fibrosis outpatient clinics at The Children’s Hospital
at Westmead or who were inpatients in the Hospital were
approached to participate in the study over an 8-month
period. The researcher making this approach was independ-
ent of the clinic team. Adolescents with a known intellectual
disability were excluded from the study, due to minimal
reading age requirements for the questionnaire measures
being used.
The study was approved by the Human Ethical Review
Committee of The Children’s Hospital at Westmead. The
purpose of the study was explained to the young person and
their parents. Consent was sought from both the young
person and their parent for those who were sixteen or under.
Those who were over sixteen gave their own consent.
2.2. Measures
2.2.1. Demographic measures
Basic demographic information about age, gender and
place of residence was obtained from the clinical notes.
2.2.2. Measures of QOL, family and psychological
functioning
Adolescents were asked to complete the following
questionnaires. A package containing a copy of each
questionnaire was provided to the young person who
completed them and then returned the package to one of
the investigators (JS).
2.2.2.1. The Cystic Fibrosis Questionnaire (CFQ). The CFQ
is an age-specific self-report Likert-scale questionnaire.
There are two age specific versions—one for 12–13 year
olds and the other for those 14 years of age and older. The
form for 12–13 year olds has 35 items, and the form for those
aged 14 years and over contains 48 items [21]. The CFQ for
those 14 years and over measures five domains of health
related quality of life (QoL): physical functioning, role limi-
tations/school performance, energy/well-being, emotional
state, and social limitations. In addition, it measures seven
Table 1
Demographics and disease severity of study subjects (n =52)
Mean age 15.06 years (SD=1.98)
Gender 51.9% male
Mean FEV1 72.4% predicted (SD=24.2)
Mean total Shwachman score 76.2 (SD=15.2)
SD=standard deviation of the mean.
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health perceptions, respiratory symptoms, digestive symp-
toms, weight symptoms and treatment constraints. The
version for 12 and 13 year olds has only 8 domains and does
not include the domains pertaining to role limitations/school
performance, energy/well-being, health perceptions or
weight symptoms. It is the first disease-specific measure of
CF to emerge in the literature and good initial psychometric
data for the English version exists [21,22].
2.2.2.2. The Family Environment Scale—3rd edition
(FES). This is a self-report scale of 90 true–false items,
which measures family functioning. It contains ten sub-
scales which are divided into three dimensions. The
relationship dimension looks at cohesion, expressiveness
and conflict. The personal growth dimension measures
independence, achievement-orientation, intellectual–cul-
tural orientation, active-recreational orientation and
moral–religious emphasis. The system maintenance dimen-
sion looks at organisation and control. The scale can be used
with children 12 years and older. It is one of the most widely
used measures of family functioning for research purposes,
and an extensive body of literature suggests it has adequate
reliability and good validity [23–25].
2.2.2.3. The SymptomChecklist-90-Revised (SCL-90-R). This
is a broad-band measure of general psychopathology
across nine symptom domains: somatisation, obsessional–
compulsions, interpersonal sensitivity, depression, anxiety,
hostility, phobic anxiety, paranoid ideation and psychoti-
cism. It contains 90 items, which are rated on a five-point
Likert scale. The scores can be used to obtain an overall
Global Severity Index (GSI) as well as generate a measure of
distress; the Positive Symptom Distress Index [26]. Caseness
is defined if the GSI T score is greater than 63, or 2 primary
dimensions T scores are greater than 63. A GSI score of over
63 places the individual above the 84th percentile compared
to the normative population. The GSI score was used as a
measure of psychopathology. As the measure is standardised
for those aged 13 years and above, in this study a separate
analysis was performed for those 13 years and over, and,
those under 13 years. The somatisation subscale included
questions which primarily relate to physical symptoms, such
as headaches, nausea and upset stomach, some of these
symptoms would be a direct result of the CF disease process
and not an indication of a possible psychological problem.
The somatisation subscale was thus excluded from the final
analysis since it was possible that this would confound the
results in this group. This did not violate the psychometric
properties of this scale.
2.2.2.4. The Hunter Opinions and Personal Expectations
Scale (HOPES). This is a self-rated questionnaire with 20
items which are rated on a five-point Likert scale. Those
scoring over 55 are rated as having Fhigh_ levels of
optimism about the future [27]. The questionnaire has beenused with adolescents aged from 16 years but has yet to be
validated in younger individuals. This questionnaire was
included as a measure of resilience.
2.2.3. Measures of disease severity
The Shwachman Score obtained from the most recent
annual review by the clinic team was used as a measure of
disease severity [28]. This is a widely used clinico-
radiological measure (with a possible total of 100 for those
with no signs or symptoms of CF) and incorporates
assessments of physical examination, general activity,
nutrition and chest X-ray findings (each scored out of a
maximum of 25). Forced expiratory volume in one second
(FEV1) expressed as a percentage of that predicted for an
individual of the same height and gender [29] was used as a
measure of lung function.
2.2.4. Analysis of data/statistics
Non-parametric statistics were used throughout because
the data did not meet the criteria for normal distribution.
Spearman’s rho was used to explore the correlations
between the different variables. The participants and non-
participants were compared using Chi-squared for nominal
categories and the Mann Whitney for age and measures of
disease severity. Results were considered statistically sig-
nificant if p0.05.3. Results
One adolescent attending the clinic was not approached as
he met our exclusion criteria in respect of intellectual
disability. In total, 80 young people were approached,
representing three-quarters of those aged 12–18 years cared
for by this clinic. Fifty-two agreed to participate, of these 40
were over 14, and 12 were under 14 years of age. The study
group therefore comprises approximately half of the patients
of that age attending the centre. The demographics and
clinical characteristics of those taking part in the study are
shown in Table 1. Those who did not wish to take part (n =28)
did not appear to be significantly different on measures of
disease severity (Shwachman score U =646.5, p =0.759;
FEV1 U =677.0, p =0.904), mean age (U =571.5, p =0.118)
or gender (v2=2.476, p =0.116) than the participants.
Not all the questionnaires had been completed, com-
pleted correctly or returned in every case, thus the numbers
completing each questionnaire are specified below.
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In general, these young people scored well on the Quality
of Life Scale (Table 2). For example, the mean score for
physical functioning for the entire group was 70.0 with a
range of 0–100, for respiratory symptoms was 63.1 with a
range of 16.7–100, while that for Body Image was 71.2 with
a range 0–100. As can be seen in Table 2, the mean scores
for those 14 and above and those for all study subjects were
very similar for all domains, indicating that the measured
Quality of Life was similar in those above and below 14
years of age.
3.2. Psychopathology
Of the 52 subjects completing the study, only 44
completed the SCL90-R. One questionnaire was excluded
because it was completed by a subject’s mother, one parent
thought it was unsuitable for her child and six adolescents
said it was too long and they did not wish to complete it.
Five of the participants, four girls and one boy, 11% of
the sample who completed the SCL90-R, were identified as
cases. The SCL90-R is standardised for young people of 13
years and above. Four 12 year-olds who completed the
questionnaire all scored in the non-clinical range. Their
results were analysed separately as they were outside the age
range for which the questionnaire is standardised. Therefore,
of those 13 and over, five young people (or 12.5% of those
13 and over) were identified as cases.
The young people identified as cases all reported
symptoms of anxiety (n =3) or obsessional–compulsive
disorder (n =2). Three also scored highly on interpersonal
sensitivity. Two of the young people (one male and one
female) were alienated from their families of origin and at
17 were both no longer living with their parents. They were
the only two adolescents interviewed who had left home.
Two of the other girls had received late diagnoses of CF, one
who had been eleven at the time, and one, 13. There was
only one other girl known to the clinic who had had a lateTable 2
Mean CF quality of life scores of subjects
All participants (n =52)
Mean scoreT sem (Ran
Physical functioning 70.0T4.1 (0–1
Energy/well-beinga
Emotional state 78.1T2.4 (33.3
Social limitations 74.2T2.8 (0–1
Body image 71.2T4.1 (0–1
Health perceptionsa
Role limitations/school performancea
Eating disturbances 84.3T3.5 (11.1
Treatment constraints 69.1T3.0 (11.1
Respiratory symptoms 63.1T2.5 (16.7
Weight symptomsa
Digestive symptoms 79.3T3.1 (0–1
a These domains are measured only in those aged 14 years and older.diagnosis, but she had been treated for lung disease most of
her life. She declined to participate in the study but had not
been identified as having any mental health or emotional
problems by the clinic team. The fourth girl had a sister who
had died of CF at the age of fourteen, which was her own
age at the time of the study.
There was no significant correlation between GSI score
and clinician measures of physical health (Shwachman
score: r =0.119; p >0.05, FEV1: r =0.143; p >0.05).
However, as seen in Fig. 1, in those 13 or over, GSI score
had a significant negative correlation with the young
person’s own rating of a number of quality of life measures
including physical functioning, emotional functioning,
body image, eating disturbance, weight problems, respira-
tory symptoms, energy, treatment constraints, role limi-
tations or school concerns, social limitations, and health
perceptions. For some of these elements (emotional
functioning, eating disturbance and body image), the
relationships were of Fmoderate_ strength (r =0.50–0.69)
according to the 5 level scale (little if any, low, moderate,
high, and very high) of Munro [30] while for others the
relationship was only of Flow_ strength (r =0.26–0.49, e.g.
physical functioning, weight problems, and respiratory
symptoms). There was no significant correlation between
GSI score and digestive symptoms (r=0.331, p =0.052).
There was no significant correlation for those under 13
between GSI and any of the quality of life dimensions:
physical functioning, emotional state, social limitations,
body image, eating disturbance, treatment constraints,
respiratory symptoms, digestive symptoms. These ques-
tionnaires were however completed by only a small number
of children in this age range (n =4).
3.3. Hope for the future
All 52 patients completed the HOPES, but one form
was incorrectly filled in and was excluded from the
analysis. Sixty nine percent (n =35) of the 51 adolescents
who completed the HOPES correctly obtained scoresParticipants 14 years and older (n =40)
ge of scores) Mean scoreT sem (Range of scores)
00) 70.7T5.0 (0–100)
59.0T3.4 (8.3–91.7)
–100) 78.8T2.9 (33.3–100)
00) 75.0T3.3 (0–100)
00) 69.7T4.8 (0–100)
64.2T4.2 (11.1–100)
77.6T4.4 (0–100)
–100) 83.6T4.3 (11.1–100)
–100) 67.2T3.4 (11.1–100)
–100) 64.1T2.5 (22.2–94.4)
71.8T5.8 (0–100)
00) 85.8T2.4 (44.4–100)
Significant correlations between psychopathology as measured by the SCL-90-R and Quality of Life (measured by the CFQ) are indicated 
as follows:-  * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001 
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0
ph
ys
ic
a
l
fu
n
ct
io
n
in
g
e
n
e
rg
y /
 
w
e
ll-
be
in
g
fe
w
e
r 
so
ci
a
l
lim
ita
tio
n
s
be
tte
r 
bo
dy
 
im
a
ge
be
tte
r 
he
a
lth
pe
rc
e
pt
io
n
s
fe
w
e
r 
e
a
tin
g
pr
o
bl
e
m
s
fe
w
e
r 
re
sp
ira
to
ry
sy
m
pt
o
m
s
fe
w
e
r 
di
ge
st
iv
e
sy
m
pt
om
s
tre
a
tm
e
n
t
co
n
st
ra
in
ts
e
m
o
tio
n
a
l s
ta
te
fe
w
e
r 
w
e
ig
ht
sy
m
pt
o
m
s
ro
le
 
lim
ita
tio
n
s 
/
sc
ho
o
l c
o
n
ce
rn
s
c
o
rr
el
at
io
n
 c
o
e
ffi
ci
en
t (r
)
** **
**
** **
**
***
*** ***
*
*
Quality of Life Measure
Fig. 1. Correlation between psychopathology and quality of life in adolescents with CF.
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for the future was negatively correlated with psychopa-
thology as measured on the GSI (r =0.516, p0.001).
There was no significant correlation between hope for the
future and the clinical ratings of disease severity as
measured by the Shwachman score (r =0.214, p>0.05)
or FEVI (r =0.128, p >0.05). However, personal hopeful-Significant correlations between optimism for the future as measured
indicated as follows:- * p ≤ 0.05, ** p ≤  0.01, and *** p ≤ 0.001 
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Fig. 2. Correlation between optimism for the future and qualityness was significantly correlated with perception of their
own physical (r =0.515, p0.001), social (r =0.617,
p 0.001) and emotional functioning (r = 0.635,
p0.001) on the quality of life measure in those 14 years
and over (see Fig. 2). In those aged 13 years or under there
was no significant correlation between personal hopeful-
ness and any measure of quality of life. by the HOPES and Quality of Life (measured by the CFQ) are
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of life in adolescents with CF aged 14 years and older.
Table 3
Relationship between family characteristics and quality of life in adolescents with CF
CF Quality of life measure
Physical
functioning
Energy
levels
Emotional
functioning
Fewer social
limitations
Better body
image
Health
perception
Role limitations/
school concerns
Fewer eating
problems
Treatment
constraints
Respiratory
symptoms
Weight
symptoms
Digestive
symptoms
n 31 31 31 31 31 31 27* 30** 30** 30** 30** 30**
Family environment characteristic
Relationship dimension
Cohesion
r 0.428 0.362 0.370 0.249 0.364 0.248 0.006 0.443 0.004 0.308 0.118 0.052
p 0.016 0.045 0.040 0.177 0.044 0.179 0.975 0.014 0.982 0.097 0.536 0.785
Expressiveness
r 0.121 0.006 0.174 0.265 0.055 0.128 0.146 0.187 0.092 0.081 0.152 0.364
p 0.517 0.977 0.349 0.150 0.770 0.493 0.467 0.322 0.627 0.670 0.424 0.048
Conflict
r 0.355 0.332 0.147 0.332 0.432 0.098 0.009 0.562 0.197 0.111 0.223 0.153
p 0.050 0.068 0.431 0.068 0.015 0.599 0.966 0.001 0.298 0.559 0.237 0.420
Personal growth dimension
Independence
r 0.325 0.258 0.212 0.199 0.334 0.398 0.004 0.264 0.251 0.382 0.255 0.263
p 0.074 0.160 0.253 0.282 0.066 0.027 0.984 0.158 0.180 0.037 0.173 0.160
Achievement orientation
r 0.348 0.227 0.269 0.142 0.146 0.131 0.152 0.303 0.132 0.156 0.029 0.024
p 0.055 0.219 0.143 0.447 0.433 0.482 0.448 0.104 0.488 0.412 0.879 0.901
Intellectual/cultural orientation
r 0.047 0.119 0.072 0.172 0.038 0.266 0.096 0.069 0.240 0.138 0.324 0.314
p 0.801 0.523 0.701 0.354 0.838 0.147 0.634 0.717 0.202 0.468 0.081 0.091
Active/recreational orientation
r 0.527 0.278 0.319 0.405 0.420 0.252 0.017 0.336 0.011 0.309 0.200 0.111
p 0.002 0.130 0.080 0.024 0.019 0.172 0.933 0.070 0.953 0.097 0.289 0.560
Moral– religious emphasis
r 0.025 0.075 0.099 0.042 0.150 0.188 0.232 0.059 0.270 0.002 0.077 0.066
p 0.895 0.689 0.596 0.822 0.422 0.311 0.244 0.755 0.149 0.992 0.685 0.730
System maintenance dimension
Organisation
r 0.113 0.127 0.213 0.152 0.240 0.058 0.008 0.277 0.012 0.075 0.022 0.139
p 0.547 0.497 0.249 0.415 0.193 0.757 0.967 0.138 0.951 0.694 0.909 0.463
Control
r 0.258 0.323 0.153 0.291 0.265 0.218 0.277 0.213 0.075 0.139 0.170 0.245
p 0.161 0.076 0.411 0.112 0.149 0.239 0.163 0.259 0.694 0.465 0.369 0.192
Significant correlations between family environment characteristics and CF Quality of Life measures are shown in italics.
T There were 4 adolescents who were not attending school and were thus unable to answer this element.
TT One adolescent did not complete this part of the questionnaire.
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Forty-two subjects completed the Family Environment
Scale but two responses were excluded from the analysis as
not all questions had been completed. An additional 10
young people did not appear to have been provided with the
questionnaire as no blank or completed forms were returned
in their questionnaire package. As correlations between
various dimensions were being explored in this study, it was
felt inappropriate to ask these young people to repeat the
study in order to obtain data for the FES.
Child cohesion, expressiveness, achievement orientation
and organisation were significantly correlated with opti-
mism about the future (cohesiveness r =0.384, p0.01;
expressiveness r=0.408, p0.01; organization r =0.398,
p0.01; achievement orientation r =0.386, p0.01).
Three of these measures were also negatively correlated
with levels of psychopathology (cohesiveness r =0.446,
p0.01; expressiveness r =0.0373, p0.05; organiza-
tion r =0.418, p0.01). Family conflict was negatively
correlated with clinical measures of physical well-being
(FEV1 r=0.373, p0.05, Shwachman score r =0.331,
p0.05) and the over 14 s perception of their physical
functioning on the quality of life measure (r =0.414,
p0.05). There was no significant correlation between the
young person’s rating of independence or physical
functioning and their clinical status (Shwachman score:
r =0.186, p =0.257, FEVI: r =0.168, p =0.300). The
relationship between family characteristics and quality of
life are shown in Table 3. There were significant
correlations between family cohesion and the quality of
life measures of physical functioning, energy levels,
emotional functioning, better body image and fewer
eating problems. In addition, child expressiveness was
negatively correlated with digestive symptoms while
family conflict was negatively associated with physical
functioning, better body image and fewer eating prob-
lems. In the personal growth dimension, independence
was significantly correlated with health perceptions and
fewer eating problems while an active-recreational ori-
entation was significantly associated with physical func-
tioning, fewer social limitations and a better body image.
Other family environment characteristics were not corre-
lated with QoL measures.4. Discussion
The most significant finding of this study is that young
people with cystic fibrosis, despite the burdens that this
disease imposes on them, are a generally well functioning
and well-adjusted group. Our results also confirm, that as
one would expect, the family relationships including levels
of cohesion, conflict and expressiveness have a significant
impact on the young people’s psychological functioning and
adjustment. In addition, we have found that in a group ofadolescents there is a lower than expected incidence of
psychopathology.
The level of individual psychopathology (12.5% in those
13 years and over) identified in this sample of young people
was lower than that reported in community samples. A
recent survey of the mental health of young people in
Australia indicates that 15–20% of children and adolescents
have a psychiatric disorder [31]. Thus, this study suggests
that young people with CF are less likely than their
physically well counterparts to have mental health prob-
lems. There are a number of reasons why this situation may
exist. It may be that the impact of CF on day to day
functioning is less significant than it was even a decade ago
so that the physical burden, and thus the psychological
impact is less significant. In Australia, where a newborn-
screening program for CF has been in place since 1981 (all
of the participants in the study were born since the program
was instituted) the median age of diagnosis is 1.8 months
[32]. Therefore, prenatal diagnosis or diagnosis at a young
age also ensures that parents are supported and linked into
services in a timely way, which may enable them in turn to
support their children more effectively. Our findings in
relation to family characteristics and the presence of
psychopathology where cohesion, expressiveness and
organisation were all negatively correlated with psychopa-
thology, support this assertion. Thus, early identification of
a child with CF and the provision of a framework of support
is likely to be a second mechanism which explains our
observed low rate of psychopathology in this group of
adolescents with CF. Two of those identified as having
significant levels of anxiety were both girls who had
been diagnosed Flate_, after they were 10 years of age (in
comparison, the median age of diagnosis in Australia is
1.8 months). This finding is consistent with the literature
suggesting that threats to a child’s health including
diagnosis of a severe chronic disease can cause traumatic
reactions in both children and their parents [33]. A late
diagnosis means that the child and their family have to
adapt to a very different view of their future and this can
be a very challenging task. Finally, the ethos of the clinic
encourages continuity of care from the physician with
good psychosocial and nursing support. Families and
young people feel supported in bringing up issues of
concern with someone they are familiar with. The
continuity of care also ensures that any emotional or
psychological issues for the young person or their parents
can usually be identified early on and support put into
place. The young people identified in this study as
having significant psychological difficulties had all been
identified by the clinic prior to the study and were
having additional psychosocial supports or psychiatric
intervention.
It could be argued that the levels of psychopathology
found in the group are lower than a similar aged adolescent
community sample because young people with CF are
thought to reach puberty later and that their psychological
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study performed at this centre, examining the effect of
newborn screening has shown that children born since the
institution of newborn screening have normal nutritional
status [34]. Further, some recent Australian data has shown
that puberty as measured by Tanner staging, bone age and
onset of menarche is not delayed in those with cystic
fibrosis [35]. No measures of pubertal development were
performed in this study and while this hypothesis cannot be
completely ruled out, we believe that the young people with
CF in this study are of an equivalent level of physical
maturity as their peers without CF.
The majority of the sample was hopeful and positive
about their future. This hopefulness was independent of
degree of physical illness (as measured by the Shwachman
score and FEV1) which CF had imposed in these young
people. This is perhaps surprising in a group who are
suffering from a life-limiting disease. It may be that some
of the younger children in the sample were of an age where
they had not developed the cognitive maturity to question
their mortality. However, in the face of a disease over
which one has limited control a positive outlook on life
may be a constructive coping strategy which enables the
young person to enjoy what they can out of life. Indeed,
lack of hope for the future in our study was correlated with
higher levels of psychopathology rather than disease
severity. Hopefulness and psychopathology were signifi-
cantly correlated with the young person’s own perceptions
of their quality of life. This suggests that emotional well-
being and quality of life is linked to hopefulness despite the
severity of the physical disease process. Hope has been
considered as an enduring characteristic of the young
person [14]. The subgroup analysis of those participating in
the study who were 13 years of age or younger,
demonstrated a lack of association between quality of life
measures and hope for the future. It is however possible
that due to the small numbers in this age group this was a
type II error. It is interesting to speculate whether the lack
of optimism about the future for young people with a life
limiting illness leads to a greater risk of psychopathology or
results from elevated levels of depression, for example. The
literature in this area would suggest that a negative view of
the future is one of the areas of cognitive distortion that
occurs in depression [36].
For the majority of adolescents with CF, their families are
crucial in guiding and supporting their growing treatment
independence and transition into adulthood. The adoles-
cent’s desire for greater independence may however,
conflict with the demands of their condition [37]. Parental
involvement and monitoring during this time is critical to
maintaining good adherence [38]. Lower family stress,
parental availability and integrative family coping have been
shown to be linked with better health outcomes [39]. Family
support and connectedness have been associated with
improved emotional health in adolescents with chronic
illnesses, whereas over protectiveness has not [40,41]. Theresults of our study indicate that family relationship
characteristics have a significant impact on the psycholog-
ical health of a young person with CF. Hope in the
adolescents studied was related to higher levels of child
expressiveness, organization and cohesion in the family.
These are factors which have been identified as important in
good adjustment and compliance in other studies of family
functioning [42,43]. Two of the five young people who were
identified as having significant psychological problems
were alienated from their families of origin.
The young people completing this study scored well in
terms of Quality of Life. In all aspects, their mean scores
were consistent with those previously published using the
same assessment tool [44,45]. This finding lends support to
the notion that our population of subjects with CF are
representative of young people with CF in general and not
just those attending our clinic, and thus our results in terms
of psychopathology and family functioning can be inferred
for other young people with CF.
The young people who had higher levels of disease
severity reported lower levels of family conflict. Adoles-
cents who came from families they viewed as being
achievement-orientated also had higher levels of personal
hopefulness. This would indicate that either pre-existing or
adopted characteristics of a family directly impact upon the
hope for the future held by a young person with CF.
Medical measures alone do not adequately reflect the
impact of a disease on daily life. Indeed, one of us has
previously found that physicians believe that CF has a more
negative impact on the life of an adolescent than the
adolescents themselves [46]. In adolescence especially, there
is a need to look at the young person’s role and social
functioning, as well as disease-specific factors such as body
image and energy levels in order to understand their
experience of CF. Their experience of their own quality of
life appears to be inextricably linked with their emotional
well-being and mental health. This study does not indicate
the direction of this association. However, the fact that
psychopathology does not appear to be related to an
objective measure of physical well-being may suggest that
the young person’s emotional state may be critical. Assessing
the young person’s perception of how the disease impacts on
their quality of life may also promote adherence to complex,
time-consuming treatment regimens [2] and help promote
successful transition between child and adult services. The
Cystic Fibrosis Questionnaire was completed very readily by
the young people in the study. The questionnaire asks
questions that are very relevant to their lives and is thus
much more acceptable than a standard screening for
psychopathology such as the SCL-90-R. Thus, it would
seem to provide a useful adjunct to the physical review
providing information on the young people’s perception of
their quality of life and highlighting those who may be at risk
of depression or other mental health problems.
The results of this study indicate that the majority of
young people with CF perceive themselves to have a good
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optimism about the future, despite the prognosis of the
disease may be essential to good psychological function-
ing. Most importantly, these attributes are independent of
the degree of their physical impairment judged by medical
measures such as the Shwachman score and lung function
testing. In addition, these results indicate that the accepted
concepts of inevitable psychopathology associated with
chronic illness need to be firmly laid to rest as far as
adolescents with CF are concerned. Recognition of these
psychological issues may be of assistance to those
involved in health care of young persons with CF and
their families.References
[1] Cystic Fibrosis Foundation, Patient Registry 2001 Annual Report,
Bethesda, Maryland.
[2] Quittner AL. Measurement of quality of life in cystic fibrosis. Curr
Opin Pulm Med 1998;4:326–31.
[3] Kotwicki RJ, Condra L, Vermeulen L, Wolf T, Douglas J, Farrell PM.
Assessing the quality of life in children with cystic fibrosis. WMJ
2001;100:50–4.
[4] Orenstein D, Nixon P, Ross E, Kaplan R. Quality of well-being in
cystic fibrosis. Chest 1989;95:344–7.
[5] Cadman D, Boyle N, Szatmari P, Orford D. Chronic illness, disability
and mental and social wellbeing: findings of the Ontario Child Health
Study. Pediatrics 1987;79:705–12.
[6] Cappelli M, McGrath PJ, Heick C, Macdonald N, Fieldman W, Rowe
P. Chronic disease and its impact: the adolescents perspective.
J Adolesc Health Care 1989;10:283–8.
[7] Lask B. Psychological aspects of cystic fibrosis. In: Hodson ME,
Geddes DM, editors. Cystic fibrosis. London’ Chapman & Hall; 1995.
[8] Boyle IR, di Sant’Agnese PA, Sack S, Millican F, Kulczycki LL.
Emotional adjustment of adolescent and young adults with cystic
fibrosis. J Pediatr 1976;88:318–26.
[9] Zeltzer L, Kellerman J, Ellenberg L, Dash J, Rigler D. Psychologic
effects of illness in adolescence. II—impact of illness in adoles-
cence—crucial issues and coping styles. J Pediatr 1980;97:132–8.
[10] Blair C, Cull A, Freeman CP. Psychosocial functioning of young
adults with cystic fibrosis and their families. Thorax 1994;49:
798–802.
[11] Anderson DL, Flume PA, Hardy KK. Psychosocial functioning of
adults with cystic fibrosis. Chest 2001;119:1079–84.
[12] Abbott J. Coping with cystic fibrosis. J R Soc Med 2003;96:42–50.
[13] Ievers CE, Drotar D. Family and parental functioning in cystic
fibrosis. J Dev Behav Pediatr 1996;17:48–55.
[14] Graetz BW, Shute RH, Sawyer MG. An Australian study of
adolescents with cystic fibrosis: perceived supportive and non-
supportive behaviour from families and friends and psychological
adjustment. J Adolesc Health 2000;26:64–9.
[15] Pendleton SM, Cavalli KS, Pargament KI, Nasr SZ. Religious/spiritual
coping in childhood cystic fibrosis: a qualitative study. Pediatrics
2002;109:E8.
[16] Goodyer IM. Risk and resilience processed in childhood and
adolescence. In: Lindstrom B, Spencer N, editors. Social pediatrics.
Oxford’ Oxford University Press; 1995.
[17] Nunn KP. Personal hopefulness: a conceptual review of the relevance
of the perceived future to psychiatry. Br J Med Psychol 1996;
69:227–45.
[18] Gudas L, Koocher G, Wypij D. Perceptions of medical compliance in
children and adolescents with cystic fibrosis. J Dev Behav Pediatr
1991;12:236–42.[19] Hubble MA, Duncan BL, Miller SD. The heart and soul of change:
what works in therapy. Washington’ American Psychological Associ-
ation; 1999.
[20] Swanston HY, Nunn KP, Oates RK, Tebbutt JS, O’Toole BI. Hoping
and coping in young people who have been sexually abused. Eur
Child Adolesc Psychiatry 1999;8:134–42.
[21] Quittner AL, Buu A, Watrous M, Davis MA. Cystic Fibrosis
Questionnaire: a health-related quality of life measure. Unpublished
User Manual (English Version 1.0); 2000.
[22] Quittner AL, Sweeny S, Watrous M, Munzenberger P, Bearss K,
Gibson Nitza A, et al. Translation and linguistic validation of a
disease-specific quality of life measure for cystic fibrosis. J Pediatr
Psychol 2000;25:403–14.
[23] Moos RH, Moos BS. Family environment scale manual. 3rd edn. Palo
Alto’ Consulting Psychologists Press; 1994.
[24] Piotrowski C. Use of tests and measures in marital and family
research. Psychol Rep 1999;84:1251–2.
[25] Moos RH. Conceptual and empirical approaches to developing family-
based assessment procedures: resolving the case of the family
environment scale. Fam Process 1990;29:199–208.
[26] Derogatis LR. Symptom checklist-90-revised: administration, scoring
and procedures manual. 3rd edn. Minneapolis’ National Computer
Systems; 1994.
[27] Nunn KP, Lewin TJ, Walton JM, Carr VJ. The construction and
characteristics of an instrument to measure personal hopefulness.
Psychol Med 1996;26:531–46.
[28] Shwachman E, Kulczycki M. Clinical evaluation and grading
criteria for patients with cystic fibrosis. Am J Dis Child 1958;6:
96–98.
[29] Polgar G, Promadhat V. Standards in pulmonary function tests. In:
Polgar G, editor. Pulmonary function testing in children: techniques
and standards. Philadelphia’ WB Saunders Co.; 1971.
[30] Munro BH. Statistical methods for health care research. 4th edn.
Philadelphia’ Lippincott, Williams & Wilkins; 2002.
[31] Sawyer MG, Arney F, Baghurst PA. The mental health of young
people in Australia: key findings from the child and adolescent
component of the national survey of mental health and well-being.
Aust N Z J Psychiatry 2001;35:806–14.
[32] Cystic Fibrosis Australia. Cystic Fibrosis in Australia and New
Zealand 2000: Annual Report of the Australasian Cystic Fibrosis
Data Registry. North Ryde, New South Wales; 2002.
[33] Landolt MA, Vollrath M, Ribi K, Gnehm HE, Sennhauser F.
Incidence and associations of parental and child posttraumatic stress
symptoms in pediatric patients. J Child Psychol Psychiatry 2003;
44:1199–207.
[34] Waters DL, Wilcken B, Irwig L, Van Asperen P, Mellis C, Simpson
JM, et al. Clinical outcomes of newborn screening for cystic fibrosis.
Arch Dis Child Fetal Neonatal Ed 1999;80:F1–7.
[35] Wainwright CE, Green RM, Schluter P, Batch J, Bell SC, Buntain
HM. Age appropriate pubertal development in cystic fibrosis.
Proceedings of the fifth Australian and New Zealand cystic fibrosis
conference; 2003. p. 118.
[36] Beck AT, Cognitive models of depression. In: Clinical advances in
cognitive psychotherapy: theory and applications. In: Leahy RL,
Dowd ET (Eds.), New York: Springer Publishing Co.
[37] Czajkowski DR, Koocher GP. Predicting medical compliance
among adolescents with cystic fibrosis. Health Psychol 1986;5:
297–305.
[38] Drotar D, Ievers C. Preliminary report: age differences in parent
and child responsibilities for management of cystic fibrosis and
insulin dependent diabetes mellitus. J Dev Behav Pediatr 1994;15:
367–74.
[39] Patterson JM, McCubbin HL, Warwick WJ. The impact of family
functioning on health changes in children with cystic fibrosis. Soc Sci
Med 1990;31:291–301.
[40] Blum R. Chronic illness and disability in adolescence. J Adolesc
Health 1992;13:364–8.
J.E. Szyndler et al. / Journal of Cystic Fibrosis 4 (2005) 135–144144[41] Wolman C, Resnick MD, Harris LJ, Blum R. Emotional well-being
among adolescents with and without chronic conditions. J Adolesc
Health 1994;15:199–204.
[42] Staab D, Wenninger K, Gebert N, Rupprath K, Bisson S, Trettin
M, et al. Quality of life in patients with cystic fibrosis and their
parents: what is important besides disease severity? Thorax 1998;
53:727–31.
[43] Boekaerts M, Roeder I. Stress, coping and adjustment in children with
a chronic disease: a review of the literature. Disabil Rehabil 1999;
21:311–37.[44] Henry B, Aussage P, Grosskoph C, Goehrs J-M. Development of the
Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in
pediatric and adult patients. Qual Life Res 2003;12:63–76.
[45] Wenninger K, Aussage P, Wahn U, Staab D, and the German Cystic
Fibrosis Questionnaire study group. The revised German cystic
fibrosis questionnaire: validation of a disease-specific health-related
quality of life instrument. Qual Life Res 2003;12:77–85.
[46] Leung SS, Steinbeck KS, Morris SL, Kohn MR, Towns SJ, Bennett
DL. Chronic illness perception in adolescence: implications for the
doctor–patient relationship. J Paediatr Child Health 1997;33:107–12.
